The effect of pentoxifylline on current perception thresholds in patients with diabetic sensory neuropathy

Journal of Diabetes and its Complications

Volumn 11, Issue 5, 1997, Pages 274-278

  Lee, Yuwen ^a   Robinson, Mary ^a   Wong, Nathan ^a   Chan, Eve ^a   Charles, M Arthur ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; PENTOXIFYLLINE; PERIPHERAL VASODILATING AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCEPTIVE THRESHOLD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSORY NEUROPATHY; SYSTOLIC BLOOD PRESSURE;

ADULT; COHORT STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETIC NEUROPATHIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LEG; MALE; MIDDLE AGED; PENTOXIFYLLINE; PERCEPTION; PERIPHERAL NERVOUS SYSTEM; SENSORY THRESHOLDS; VASODILATOR AGENTS;

EID: 0030845373     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(96)00077-3     Document Type: Article

References (13)

1. Vinik A, Mitchell B: Clinical aspects of diabetic neuropathies. Diabetes Metab Rev 4:223-253, 1988.
2. Gabbay KH: The sorbitol pathway and the complications of diabetes. N Engl J Med 288:831-836, 1973.
3. Pirart J: Diabetic neuropathy: A metabolic or vascular disease? Diabetes 14:1-9, 1965.
4. The Diabetes Control and Complications Trial (DCCT). N Engl J Med 329:683-689, 1993.
5. Sima A, Bril V, Nathaniel V: Regeneration and repair of myelinated fibers in sural nerve biopsy specimens from patients with diabetic and neuropathy treated with sorbinil. N Engl J Med 319:548-555, 1988.
6. Kirchain W: Aldose reductase inhibitors. Pharmacotherapy 100:326-336, 1990.
7. Dyck P: Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathies. Ann Neurol 19:425-439, 1986.
8. Cohen S: Pentoxifylline in the treatment of distal diabetic neuropathy. Angiology 42:741-746, 1991.
9. Roeren T: Photoplethysmographic documentation of improved microcirculation after pentoxifylline therapy. Angiology 39:929-933, 1988.
10. Cohen K: Lack of clonidine and pentoxifylline in short-term therapy of diabetic peripheral neuropathy. Diabetes Care 13:1074-1077, 1990.
11. Rendell M: Skin blood flow and current perception in pentoxifylline-treated diabetic neuropathy. Angiology 43:843-851, 1992.
12. Georgitis WJ: Trial of Pentoxifylline for Diabetic Impotence. Diabetes Care 18:345-352, 1995.
13. Sebag J, Tang M, Brown S, Sadun A, Charles MA: Effects of pentoxifylline on choroidal blood flow in nonproliferative diabetic retinopathy. Angiology 45:429-433, 1994.